Orange Book product · Brand (NDA)
AGGRENOX
ASPIRIN; DIPYRIDAMOLE
At a glance
Nov 22, 1999
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 22, 1999
27 yr ago
Today
Pharmaceutical detail
Active ingredient
ASPIRIN; DIPYRIDAMOLE
Strength
25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 020884
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2021ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 209929 · MICRO LABS
- 2019ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 210318 · GLENMARK SPECLT
- 2019ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 204552 · CHARTWELL MOLECULAR
- 2018ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 209048 · DR REDDYS
- 2018ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 208572 · SUN PHARM
- 2017ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 206753 · ZYDUS PHARMS
- 2017ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 206964 · ANI PHARMS
- 2017ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 207944 · PH HEALTH
- 2017ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 206739 · SANDOZ
- 2016ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 206392 · AMNEAL PHARMS
- 2009ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 078804 · BARR
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
